KRAS and infection: To test if DENV NS3 also promotes RIPK1 for lysosomal or proteasomal degradation, HEK293T cells were treated with the lysosome inhibitors NH4Cl and chloroquine (CLQ), or the proteasome inhibitor MG132 following DENV2 infection and transfection of the Flag-RIPK.